Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

HealthStream Inc reaffirms FY 2014 guidance


Monday, 21 Apr 2014 04:30pm EDT 

HealthStream Inc:Anticipates that FY 2014 consolidated revenues will grow by 25 pct. to 29 pct. as compared to FY 2013, which revenue growth reflects the impact of the deferred revenue write-down related to HCCS acquisition.Anticipates that FY 2014 operating income (EBIT) will decrease between 2 pct. and 11 pct. over FY 2013 results.Reported revenue of $133.11 million and operating income of $15.51 million in FY 2013.FY 2014 revenue estimate of $166.91 million and EBIT of $15.32 million - Thomson Reuters I/B/E/S. 

Company Quote

26.15
 --
2 Mar 2015